Merck (MRK) is a publicly traded Healthcare sector company. As of May 20, 2026, MRK trades at $114.00 with a market cap of $278.00B and a P/E ratio of 31.77. MRK moved -1.07% today. Year to date, MRK is +5.17%; over the trailing twelve months it is +44.93%. Its 52-week range spans $73.31 to $125.14. Analyst consensus is buy with an average price target of $135.61. Rallies surfaces MRK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MRK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $114.00 |
| Market Cap | $278.00B |
| P/E Ratio | 31.77 |
| EPS | $3.57 |
| Dividend Yield | 0.85% |
| 52-Week High | $125.14 |
| 52-Week Low | $73.31 |
| Volume | 5.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.77B |
| Net Income | $8.93B |
| Gross Margin | 73.91% |
20 analysts cover MRK: 0 strong buy, 13 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $135.61.